Catalio Capital Management, LP vs OrbiMed
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Catalio Capital Management, LP | OrbiMed | |
|---|---|---|
| Type | Crossover fund | Venture capital |
| HQ | New York | New York |
| Founded | 2020 | 1999 |
| Check size | — | $1M – $75M |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Digital Health, Healthtech, Longevity, Medical Devices | Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $2.2B | $20.6B |
| Tracked investments | 106 | 205 |
| Exits (acquired/public) | 2 | — |
| Dated deals, last 24 mo | 3 | 5 |
Shared portfolio · 5
ArriVent BioPharmaIambicOdyssey TherapeuticsOncusp TherapeuticsPerfuse Therapeutics
Frequently asked questions
- Do Catalio Capital Management, LP and OrbiMed invest together?
- Yes — Catalio Capital Management, LP and OrbiMed appear together in 5 tracked portfolio companies, including ArriVent BioPharma, Iambic, Odyssey Therapeutics, Oncusp Therapeutics, Perfuse Therapeutics.